The development of a [211at]-astatinated endoradiotherapeutic drug: Part II. Therapeutic results for transplanted adenocarcinoma of the rectum in mice and associated studies
- 30 April 1994
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 29 (1) , 115-124
- https://doi.org/10.1016/0360-3016(94)90233-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The development of a [211at]-astatinated endoradiotherapeutic drug: Part I. Localization by α-particle autoradiography in a murine tumor modelInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Toxicity of Astatine-211 in the MouseHuman Toxicology, 1988
- Astatine-211: Its possible applications in cancer therapyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
- Biodistribution of 6-[211At]astato-2-methyl-1,4-naphthoquinol bis(diphosphate salt) and 211At− in mice with a transplanted rectal adenocarcinomaThe International Journal of Applied Radiation and Isotopes, 1984
- The in vitro selective concentration of an 125I-iodinated compound in human tumor cellsInternational Journal of Radiation Oncology*Biology*Physics, 1983
- 6-[125I]-iodo-2-methyl-1,4-naphthoquinol bis(diammonium phosphate): a new potential anti-tumour drugJournal of the Chemical Society, Chemical Communications, 1979
- Selective Uptake of A Radioactive Drug Into Human Tumour Cells Growing in Tissue CultureActa Radiologica: Therapy, Physics, Biology, 1969
- The Effect of Oxygen on Impairment of the Proliferative Capacity of Human Cells in Culture by Ionizing Radiations of Different LETInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1966
- Impairment of the Proliferative Capacity of Human Cells in Culture by α-particles with Differing Linear-energy TransferInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1964
- 676. A radioactive drug: 2-methyl-6-tritio-1,4-naphthaquinol bis-(disodium phosphate) and 2-methyl-5,6,7-tritritio-1,4-naphthaquinol bis(disodium phosphate)Journal of the Chemical Society, 1962